Sleep Articles A-Z

Generic Amphetamine and Dextroamphetamine - Methylphenidate and D2 Receptors
This page contains links to eMedTV Sleep Articles containing information on subjects from Generic Amphetamine and Dextroamphetamine to Methylphenidate and D2 Receptors. The information is organized alphabetically; the "Favorite Articles" contains the top articles on this page. Links in the box will take you directly to the articles; those same links are available with a short description further down the page.
 Favorite Articles 
 
 

Generic Amphetamine and Dextroamphetamine

This eMedTV article explains that the patent for amphetamine and dextroamphetamine has expired, allowing a generic version of the drug to be manufactured and sold. This page also lists the strengths of generic amphetamine and dextroamphetamine.

Generic Dexmethylphenidate

Dexmethylphenidate is currently available in generic form. This eMedTV article gives an overview of generic dexmethylphenidate, including information on who manufactures it and how it compares to the brand-name version of the drug.

Generic Dextroamphetamine

As explained in this eMedTV segment, generic dextroamphetamine is available in two forms and three strengths. This article discusses these generic versions of Dexedrine in more detail and includes a list of companies that manufacture the drug.

Generic Eszopiclone

There is currently no generic eszopiclone available on the market. This eMedTV article discusses when generic eszopiclone products are expected to become available and explains the difference between a generic name and a generic version of a drug.

Generic Nuvigil

At this time, there are no generic Nuvigil products licensed for sale. This page from the eMedTV Web site offers information on when a generic version of the drug will be available and explains the difference between armodafinil and generic Nuvigil.

Generic ProSom

Generic ProSom is currently available in two strengths: estazolam 1 mg and estazolam 2 mg. This eMedTV article explains why the brand-name medication is no longer manufactured and provides a list of companies that make generic ProSom.

Generic Provigil

At this time, no generic Provigil products are available on the market. This eMedTV Web page explains when a generic version of the drug may be available and discusses the potential dangers of buying so-called "generic Provigil" before this occurs.

Generic Ramelteon

Generic ramelteon will not be available until at least 2017, when ramelteon's current patent expires. This eMedTV page provides more details about the drug's patent and explains the difference between a generic name and a generic version of a drug.

Generic Versed

Versed is currently available in a generic form. This selection from the eMedTV Web site describes generic Versed in more detail, explaining how the FDA has determined that generic Versed is as good as the brand-name medication.

Generic Zaleplon

The patent for Sonata has expired, and generic zaleplon is now available. This eMedTV segment offers an overview of generic zaleplon, including information on its available strengths and the manufacturers of it.

Good Sleep Habits

As this eMedTV article explains, good sleep habits include: exercising during the day, going to sleep at the same time each night, and avoiding caffeine late in the day. This page suggests several more good sleep habits.

Methylphenidate

Methylphenidate is a medication that is used for the treatment of ADHD and narcolepsy. This eMedTV segment explains how the drug works, offers precautions to be aware of when taking the medication, lists possible side effects, and more.

Methylphenidate and Alcohol

Methylphenidate and alcohol may potentially be a dangerous combination. As this eMedTV resource explains, although the exact interaction is unknown, alcohol may potentially intensify the effects of a stimulant like methylphenidate.

Methylphenidate and D2 Receptors

Methylphenidate is effective in treating ADHD because it increases the binding of dopamine to D2 receptors. This eMedTV article explains the link between methylphenidate and D2 receptors, and discusses the risk of drug abuse with the medication.